Economic Evaluation of Insulin Lispro versus Neutral (Regular) Insulin Therapy Using a Willingness-To-Pay Approach

By Davey P.  

PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. : 347-358

Adis International

Access to resources Recommend Favorite

The Economic Value of a New Insulin Preparation, Humalog Mix 25™: Measured by a Willingness-To-Pay Approach

By Dranitsaris G.  

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 275-287

Adis International

Access to resources Recommend Favorite

The Cost-Benefit of Cholinesterase Inhibitors in Mild to Moderate Dementia: A Willingness-To-Pay Approach

By Wu G.   Lanctôt K.L.   Herrmann N.   Moosa S.   Oh P.I.  

CNS Drugs, Vol. 17, Iss. 14, 2003-01 ,pp. : 1045-1057

Adis International

Access to resources Recommend Favorite

Valuation of Symptomatic Hepatitis A in Adults: Estimates Based on Time Trade-Off and Willingness-To-Pay Measurement

By Jacobs R.J.  

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 739-747

Adis International

Access to resources Recommend Favorite

Questioning willingness to pay

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite